Skip to main content
Craig Erickson, MD, Psychiatry, Cincinnati, OH, Cincinnati Children's Hospital Medical Center

CraigA.EricksonMD

Psychiatry Cincinnati, OH

Child & Adolescent Psychiatry

Professor, Cincinnati Children’s Hospital, University of Cincinnati College of Medicine

Dr. Erickson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Erickson's full profile

Already have an account?

Education & Training

  • Indiana University School of Medicine (Indianapolis)
    Indiana University School of Medicine (Indianapolis)Residency, Psychiatry, 2004 - 2007
  • Indiana University School of Medicine/Methodist Hospital
    Indiana University School of Medicine/Methodist HospitalInternship, Transitional Year, 2003 - 2004
  • University of Cincinnati College of Medicine
    University of Cincinnati College of MedicineClass of 2003

Certifications & Licensure

  • KY State Medical License
    KY State Medical License 2021 - 2025
  • IN State Medical License
    IN State Medical License 2006 - 2025
  • OH State Medical License
    OH State Medical License 2012 - 2025
  • American Board of Psychiatry and Neurology Psychiatry
  • American Board of Psychiatry and Neurology Child & Adolescent Psychiatry

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Author Correction: Impaired Perceptual Learning in a Mouse Model of Fragile X Syndrome Is Mediated by Parvalbumin Neuron Dysfunction and Is Reversible  
    Ernest Pedapati, Craig A Erickson, Nature
  • Full Length Article Pharmacological Management of Behavioral Disturbances in Children and Adolescents with Autism Spectrum Disorders  
    Craig A. Erickson, Martine Lamy, ScienceDirect
  • Impaired Perceptual Learning in a Mouse Model of Fragile X Syndrome Is Mediated by Parvalbumin Neuron Dysfunction and Is Reversible  
    Ernest Pedapati, Craig A Erickson, Nature

Press Mentions

  • Going on Trial: Serotonin Drug; Psilocybin Phase 2; Placebo Response Data
    Going on Trial: Serotonin Drug; Psilocybin Phase 2; Placebo Response DataApril 28th, 2023
  • Finding a Path Forward for Fragile X Drugs
    Finding a Path Forward for Fragile X DrugsSeptember 23rd, 2021
  • New Guidelines to Improve Inpatient Care for Kids with Autism
    New Guidelines to Improve Inpatient Care for Kids with AutismFebruary 10th, 2016
  • Join now to see all

Hospital Affiliations